4,6-Dichloro-5-(5-(trifluoromethyl)benzo[d]thiazol-2-yl)pyrimidin-2-amine

Catalog No. :
ACTTQQ611
CAS No. :
1208987-38-5
Molecular Formula :
C12H5Cl2F3N4S
Molecular Weight :
365.17

IUPAC Name:4,6-dichloro-5-(5-(trifluoromethyl)benzo[d]thiazol-2-yl)pyrimidin-2-amine

4,6-Dichloro-5-(5-(trifluoromethyl)benzo[d]thiazol-2-yl)pyrimidin-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$958.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,6-Dichloro-5-(5-(trifluoromethyl)benzo[d]thiazol-2-yl)pyrimidin-2-amine
IUPAC Name4,6-dichloro-5-(5-(trifluoromethyl)benzo[d]thiazol-2-yl)pyrimidin-2-amine
MDL No.MFCD17926262
Molecular FormulaC12H5Cl2F3N4S
Molecular Weight365.17
SMILESNC1=NC(Cl)=C(C2=NC3=CC(C(F)(F)F)=CC=C3S2)C(Cl)=N1
InChI KeyAFTVMGZOKQFHDH-UHFFFAOYSA-N
Synonym4,6-DICHLORO-5-(5-(TRIFLUOROMETHYL)BENZO[D]THIAZOL-2-YL)PYRIMIDIN-2-AMINE;2-Pyrimidinamine, 4,6-dichloro-5-[5-(trifluoromethyl)-2-benzothiazolyl]-
CAS No.1208987-38-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTTQQ611 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSCPW067 route compound structure diagram
    ACSCPW0671188047-34-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTTQQ611 route product structure diagram
    ACTTQQ6111208987-38-5
Inquiry

2. ACTTQQ611 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTTQQ611 route product structure diagram
    ACTTQQ6111208987-38-5
Inquiry

Comments (0)